Correlation Between Viridian Therapeutics and Intellia Therapeutics
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Intellia Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Intellia Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Intellia Therapeutics, you can compare the effects of market volatilities on Viridian Therapeutics and Intellia Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Intellia Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Intellia Therapeutics.
Diversification Opportunities for Viridian Therapeutics and Intellia Therapeutics
-0.46 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Viridian and Intellia is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Intellia Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intellia Therapeutics and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Intellia Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intellia Therapeutics has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Intellia Therapeutics go up and down completely randomly.
Pair Corralation between Viridian Therapeutics and Intellia Therapeutics
Given the investment horizon of 90 days Viridian Therapeutics is expected to generate 1.04 times more return on investment than Intellia Therapeutics. However, Viridian Therapeutics is 1.04 times more volatile than Intellia Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Intellia Therapeutics is currently generating about -0.04 per unit of risk. If you would invest 2,750 in Viridian Therapeutics on August 23, 2024 and sell it today you would lose (788.00) from holding Viridian Therapeutics or give up 28.65% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viridian Therapeutics vs. Intellia Therapeutics
Performance |
| Timeline |
| Viridian Therapeutics |
| Intellia Therapeutics |
Viridian Therapeutics and Intellia Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viridian Therapeutics and Intellia Therapeutics
The main advantage of trading using opposite Viridian Therapeutics and Intellia Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Intellia Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intellia Therapeutics will offset losses from the drop in Intellia Therapeutics' long position.| Viridian Therapeutics vs. Nuvalent | Viridian Therapeutics vs. Arcellx | Viridian Therapeutics vs. Vaxcyte | Viridian Therapeutics vs. Crinetics Pharmaceuticals |
| Intellia Therapeutics vs. Editas Medicine | Intellia Therapeutics vs. Caribou Biosciences | Intellia Therapeutics vs. Crispr Therapeutics AG | Intellia Therapeutics vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |